Overview
Yingyu Nan practices practicing medicine in Chongqing, China.
Their clinical expertise encompasses Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma, and B-Cell Lymphoma.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 1 clinical trial.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Frequently Asked Questions about Yingyu Nan
Is Yingyu Nan a top-rated expert for Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Yingyu Nan is classified as an Experienced expert for Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yingyu Nan participate in research or clinical trials?
Yes. Yingyu Nan has published 10 articles and abstracts on conditions like Hodgkin Lymphoma. You can view a list of Yingyu Nan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- B-Cell LymphomaNan isExperienced. Learn about B-Cell Lymphoma.
- Burkitt LymphomaNan isExperienced. Learn about Burkitt Lymphoma.
- Hodgkin LymphomaNan isExperienced. Learn about Hodgkin Lymphoma.
- Non-Hodgkin LymphomaNan isExperienced. Learn about Non-Hodgkin Lymphoma.